Kiadis Pharma N.V. | |
Stock Exchange | Euronext - Alternext Amsterdam |
EPS |
EUR1.46 |
Market Cap |
EUR175.91 M |
Shares Outstanding |
29.56 M |
Public Float |
16.61 M |
Kiadis Pharma N.V. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
20.12 M |
Public Float |
- |
Address |
Paasheuvelweg 25 Amsterdam Noord-Holland 1105 BP Netherlands |
Employees | - |
Website | http://www.kiadis.com |
Updated | 07/08/2019 |
Kiadis Pharma NV is a clinical stage biopharmaceutical company. It engages in the research, development, and future commercialization of cell-based immunotherapy products for treatment of blood cancers and inherited blood disorders. The company provide the products for Allodepleted T-cell ImmunotheRapeutics that are based on its theralux platform. |